News
The DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m ...
Regeneron is buying the assets of 23andMe, which filed for Chapter 11 bankruptcy in March after facing a series of hurdles ...
What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.
The deal would put the DNA data of millions of customers in the hands of a pharmaceutical company, which hopes to supercharge ...
Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million ...
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback